Press Enter to search · ESC to close

US Stocks

Moderna’s Pre-Market Gains Expand to 30%

Moderna’s stock surged 30% in pre-market trading, marking a significant move for the biotech company. The sharp rise suggests strong investor sentiment, possibly driven by recent news or developments. This rally highlights the volatility and momentum in the pharmaceutical sector.

Original source

Share

Related News

TREE NEWS share card
Long-press image above → Save to Photos / Share
Pitch us Feedback